Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Health Catalyst, Inc. (Nasdaq: HCAT) is a leading provider of data and analytics technology and services to healthcare organizations. Founded by healthcare veterans, the company specializes in building comprehensive data warehousing and process improvement solutions, aiming to significantly enhance healthcare delivery. Health Catalyst's innovative solutions are powered by its adaptive data architecture, which uses a late-binding bus model for agile and quick implementation.
The company operates primarily through two segments: Technology and Professional Services. The Technology segment is the key revenue driver, providing data platforms, analytics applications, and support services under cloud-based subscriptions, time-based licenses, and maintenance agreements. The Professional Services segment offers analytics, implementation, strategic advisory, outsourcing, and improvement services, enabling clients to maximize the utility of Health Catalyst's technological offerings.
Health Catalyst has recently gained recognition with several achievements:
- VitalCDM: Ranked number one in the Revenue Cycle - Chargemaster Management category of the 2024 Best in KLAS: Software & Services.
- MeasureAble™: Achieved ONC-Health IT 2015 Edition Certification, allowing its use for various quality reporting programs.
- Able Health Registry: Received QPP Qualified Registry approval for the 2024 performance year from CMS.
- Acquisition of Carevive Systems: Strengthened their capabilities in oncology data analytics, improving patient care and outcomes.
Financially, Health Catalyst continues to show promising trends, with forward-looking revenue and EBITDA guidance indicating growth. The company frequently updates its investors through quarterly earnings calls and reports, reflecting transparency and financial health.
Health Catalyst envisions a future where all healthcare decisions are data-informed, leveraging a cloud-based data platform encompassing over 100 million patient records and trillions of data points. This commitment to data-informed decision-making is at the core of its mission to drive measurable improvements in clinical, financial, and operational metrics for healthcare organizations.
For more information, visit the Health Catalyst Investor Relations page.
Health Catalyst (Nasdaq: HCAT) announced its partnership with Temple University Health System on Feb 23, 2022. Temple Health will implement PowerCosting™ from Health Catalyst's Financial Empowerment Suite to enhance financial performance and clinical outcomes. CFO Nick Barcellona emphasized the strategic investment for delivering high-value patient care. This engagement aims to provide insights into true costs and improve resource utilization amidst challenges like shifting payer mixes and rising expenses. Health Catalyst’s CEO Dan Burton expressed confidence in the partnership's potential for measurable healthcare improvements.
Health Catalyst (Nasdaq: HCAT) has announced a definitive agreement to acquire KPI Ninja, a provider of interoperability solutions and population health analytics based in Lincoln, Nebraska. The acquisition is expected to enhance Health Catalyst's data processing capabilities and expand its service offerings. KPI Ninja's technology will integrate seamlessly with Health Catalyst's Data Operating System, empowering clients to build customized clinical solutions. The deal aims to strengthen Health Catalyst's position in the healthcare analytics market, with a focus on uninterrupted service delivery to existing KPI Ninja clients.
Health Catalyst, Inc. (Nasdaq: HCAT) will announce its fourth quarter and full year 2021 operational results on March 1, 2022, after market close. A conference call will follow at 5 p.m. E.T. that day, providing insights into the company's performance. Interested parties can access the call by calling (877) 295-1104 for U.S. participants or (470) 495-9486 for international attendees. The event will be available via a live audio webcast, with a replay accessible shortly after the call.
Health Catalyst, a leading provider of data and analytics technology in healthcare, announced its participation in the 40th Annual J.P. Morgan Healthcare Conference. Key executives including CEO Dan Burton, CFO Bryan Hunt, and SVP Adam Brown will present on January 11, 2022, at 3:45 p.m. ET. An audio replay will be available on their investor relations website. With a cloud-based platform powered by over 100 million patient records, Health Catalyst aims to drive data-informed healthcare improvements for its clients.
Health Catalyst, a leader in data and analytics for healthcare, will participate in two investor conferences. CFO Bryan Hunt and SVP Adam Brown will represent the company at the Piper Sandler 33rd Annual Healthcare Conference on December 2, 2021, featuring a fireside chat and meetings. On December 1, 2021, they will also attend the Evercore ISI HealthCONx Conference at 3:30 p.m. EST, which includes a fireside chat and one-on-one meetings. Health Catalyst aims to drive data-informed healthcare improvements using its cloud-based platform, enhancing clinical, financial, and operational outcomes.
Health Catalyst, Inc. (HCAT) has announced a strategic partnership with Datavant to enhance research and clinical care through connected health data. This collaboration aims to reduce waste in patient recruitment for clinical trials by using tokenized, de-identified data within the Health Catalyst Research Network™. The partnership will facilitate data connectivity throughout the study life cycle, improving pre-trial feasibility, patient eligibility, and long-term safety analysis. Leaders from both companies emphasize the potential to broaden patient access and improve health outcomes through better data sharing.
Health Catalyst (NASDAQ: HCAT) reported a strong performance for Q3 2021, exceeding revenue and Adjusted EBITDA guidance. Key financial metrics show total revenue of $61.737 million, a 31% year-over-year increase, driven by 37% growth in technology revenue and 22% in professional services. Despite these gains, the company reported a 46% rise in net loss, reaching $40.014 million. Adjusted Technology Gross Profit increased 40% to $26.731 million, reflecting a 70% gross margin. The financial outlook remains cautiously optimistic.
Health Catalyst (Nasdaq: HCAT) will release its 2021 third quarter operating results on November 9, 2021, after market close. A conference call to discuss these results is scheduled for 5 p.m. E.T. the same day. Participants can join the call via phone or through a live audio webcast available on the company's investor relations website. Health Catalyst provides data and analytics technology to healthcare organizations, leveraging a cloud-based platform with data from over 100 million patient records to drive improvements in clinical, financial, and operational outcomes.
Health Catalyst (Nasdaq: HCAT) announced its participation in the Cantor Global Healthcare Conference on September 30, 2021, featuring a fireside chat at 1:20 p.m. ET. The company's CFO, Bryan Hunt, and SVP of Investor Relations, Adam Brown, will represent the organization. Health Catalyst provides data and analytics technology and services aimed at enhancing healthcare performance. Its cloud-based platform leverages data from over 100 million patient records to drive measurable improvements in clinical, financial, and operational areas.
Health Catalyst (Nasdaq: HCAT) announced the addition of Matt Revis to its leadership team, effective August 31, 2021. Revis, previously President and COO of Twistle, will report to COO Paul Horstmeier. He aims to enhance patient engagement technology for better healthcare outcomes. Prior to Twistle, Revis held significant roles at Jibo and Nuance Communications, contributing to product innovation and healthcare strategy. CEO Dan Burton praised Revis's leadership in advancing Health Catalyst's mission of measurable healthcare improvement.
FAQ
What is the current stock price of Health Catalyst (HCAT)?
What is the market cap of Health Catalyst (HCAT)?
What does Health Catalyst, Inc. do?
What are the main segments of Health Catalyst's business?
What recent achievements has Health Catalyst made?
What is the adaptive data architecture?
How does Health Catalyst generate its revenue?
What is the Best in KLAS ranking?
What is the significance of the MeasureAble™ ONC-Health IT certification?
How does the acquisition of Carevive Systems benefit Health Catalyst?
How does Health Catalyst support its clients?
Where can I find more information about Health Catalyst's financial performance?
